Johnson and Johnson

Americans 16+ Are Eligible for COVID-19 Vaccine

As of yesterday, Monday, April 19, all Americans ages 16+ are eligible to get the COVID-19 vaccine. According to the CDC’s COVID Data Tracker, over 132 million Americans have received one dose of the vaccine, and over 85 million have been fully vaccinated against the novel coronavirus. This 85 million figure represents 64.9% of Americans 65+ years of age. 

Read More »

Adenovirus Vaccines Shown to Have Hematological Side Effect Concerns

As of yesterday, 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered throughout the United States. As of today, the CDC and FDA announced that they are reviewing six reported cases of a rare severe type of blood clot in individuals after receiving the vaccine” and are recommending a pause in the use of the single-dose Johnson & Johnson COVID-19 vaccine until a more thorough investigation can be conducted. The CDC will convene a meeting of the Advisory Committee on immunization practices (ACIP) tomorrow, Wednesday, April 14th, to further review these cases and assess their potential significance, and this analysis will also be reviewed by the FDA.

Read More »

The Johnson & Johnson COVID Vaccine Receives Emergency Use Authorization by the FDA

The J&J COVID vaccine received emergency use authorization (EUA) by the FDA this past weekend. This single-shot vaccine is the third COVID vaccine to be released in the United States, with plans to deliver 16 million doses to the federal government by the end of March. Due to production issues, this will be significantly less than the 37 million dose figure released by J&J while recommendation by the FDA was still under review. The first 3.9 million doses, created in J&J’s Netherland factory, are expected to arrive in America by today, March 2.

Read More »